Introduction
Status epilepticus (SE) is a neurological emergency associated with high mortality (10-30%) occurring predominately within 30 days of the initial convulsive activity.
1 SE is loosely defined as a single or multiple recurring seizures lasting a minimum of 30 min, although there is now a general consensus that seizure duration exceeding 5-10 min should be treated as SE. 2 Previous studies have shown that impaired autonomic regulation and seizureinduced cardiorespiratory alterations can occur during epileptic discharge, leading to cardiac arrhythmias, autonomic imbalance and hypoxia. 3 Symptoms of increased sympathetic activation are frequently observed during seizures, with tachycardia reported in a majority of clinical presentations. [3] [4] [5] Electrocardiogram (ECG)
wave abnormalities have been reported in 35% of seizures and include atrial fibrillation, ventricular premature depolarisation, QT prolongation and atrioventricular block. 6, 7 Most changes are benign, however potentially serious changes occur in 6-13% of seizures. 5, 6 Death following SE may result as a consequence of uncontrolled tachycardia leading to malignant ventricular tachyarrhythmia's and long-term myocardial damage. 3 Ictal bradycardia (<40 b.p.m.) is rarely reported, occurring in 2% of seizures but should not be dismissed as a potential contributor to sudden cardiac death. 6, 7 Chemoconvulsant agents have been used to reproduce many of the features of acquired human epilepsy in rodent models.
Systemic administration of muscarinic agonists such as pilocarpine, or excitotoxins such as kainic acid (KA) produces SE and neuropathology. 9, 10 By binding to a-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) and KA receptors in the brain, KA and domoic acid can initiate persistent hippocampal hyperexcitability which may spread to other brain regions. 11 Excitotoxic seizure induction with KA in rat models produces escalating levels of behavioural responses which include head tremors, wet dog shakes (WDS) and eventually clonic-tonic convulsions. 12, 13 Previous studies by our group demonstrated that neither KA nor domoic acid produce direct toxic effects on rat cardiomyocyte or isolated heart preparations. 14 Furthermore, we have shown that domoic acid-induced SE produces identical patterns of structural cardiomyopathy, irrespective of whether the excitotoxin is delivered through central or systemic routes.
14 Current interventions for the management of SE include the use of anti-epileptic medications with benzodiazepines as a first-line measure and phenytoin, phenobarbital and valproate reserved for unresolved SE. 15, 16 SE however can remain refractory in many cases, with 13% indicated to remain uncontrolled even after a third-line intervention. 17 Not surprisingly, sudden cardiac death has been associated with prolonged or drug-refractory SE. 1 In this study, we examined the hypothesis that the cardiomyopathy consequent to the development of SE, occurs at least in part, from a centrally-evoked activation of cardiac sympathetic nerves and that the cardiac structural damage and dysfunction arising may be mitigated by prophylactic treatment with adrenergic modulators.
Clonidine, a pre-synaptic a 2 adrenoreceptor agonist, was utilised for its ability to centrally reduce noradrenaline/adrenaline release whilst increasing vagal activity, thereby simultaneously producing sympatholytic and parasympathomimetic effects. 18, 19 The results of this study provide new insight into the ECG changes which occur during a seizure and suggest potential new therapeutic approaches to reduce the ensuing cardiac damage.
Materials and methods

Materials
All reagents were purchased from BDH (Palmerston North, New Zealand) and Sigma-Aldrich (Auckland, New Zealand). KA (Tocris, Bristol, UK) and clonidine (Sapphire Bioscience PTY (New South Wales, Australia) were dissolved in normal saline. Surgical materials and drugs were obtained from the University of Otago Animal Welfare Office. 
Animals
Experimental protocol
Combined ECG and ECoG recordings were obtained in conscious animals through the use of implantable radiotelemeters (Telemetry Research, Auckland, New Zealand) to avoid any confounding effects of anaesthetics on cardiovascular responses. 9, 20 Following implantation of the radiotelemeters, animals were randomly allocated into saline-control (no seizure induction, n = 5), saline-KA (saline-pretreated, n = 10) or clonidine-KA (clonidine-pretreated, n = 5) treatment groups. Saline or clonidine (100 mg/kg, sc) were administered twice daily, three days prior to KA challenge and for the duration of the experiment. 19 No animals died prematurely following any drug treatments.
Surgical implantation of telemetric transmitters
Animals were administered Strepcin (benzylpenicillin and dihydrostreptomycin, 250 IU) and carprofen (5 mg/kg, sc) prior to surgery and once every 24 h post-operatively for 3 days. Anaesthesia was elicited using ketamine (75 mg/kg, sc), domitor (medetomidine hydrochloride; 0.5 mg/kg, sc) and atropine (0.05 mg/kg, sc). Body temperature was maintained at 37 8C throughout the surgery. Transmitter implantation and electrode positioning procedures were performed as previously described. 13, 21 Animals were housed individually post-surgery and left to recovery for 7 days before seizure induction.
Seizure induction and telemetric/behavioural recordings
The behavioural study was performed in a custom-made perspex observation chamber (1 m Â 50 cm Â 50 cm). Each rat was left to acclimatise in the chamber prior to study initiation. ECoG and ECG were sampled at 2000 Hz, with receiver filters set to 0.1 Hz high pass and 1000 Hz low pass using a Powerlab 2/25 signal conditioner and LabChart v.6 Pro software (AD Instruments, Sydney, Australia). ECoG, ECG and behavioural data were simultaneously recorded during a 20 min baseline period and for 2 h post-saline or KA administration. Seizures were induced by a single injection of KA (10 mg/kg, sc, maximum volume of 0.35 mL). The control animals were treated with an equivalent volume of saline subcutaneously. Following treatment, the rat was immediately returned to the chamber for behavioural observation. Behaviour was recorded every 15 s for 2 h with discrete changes in behavioural state additionally reported as they occurred. Behaviours were recorded by three different pre-trained observers using an agreed 5-point scale as previously described. 12, 13 Normal behaviours (Level 0), discomfort behaviours (Level 1), seizure behaviours confined to the head (Level 2), seizure behaviours associated with limbs or trunk such as wet dog shakes (WDS; Level 3), generalised seizure behaviours (Level 4) and clonic-tonic convulsion (Level 5). The cumulative score was determined as the sum of the maximum score every 15 s over the 2 h recording period. Behavioural seizures could not be conducted in a blinded manner and is a limitation of this study.
ECG and ECoG analysis
Recorded data were post-analysed blindly using pre-established/fixed algorithms within Lab Chart 6 Pro Software. ECG data was analysed using the ECG Analysis module software in order to assess heart rate (HR), QT intervals and T wave amplitudes. Data were analysed every five minutes in one minute blocks over the 2 h observation period. The corrected QT (QTc) was calculated in order to adjust for rate by applying the Mitchell algorithm to the QT interval recordings, QTc = QT 0 /(RR/100) 1/2 . 22 This algorithm is designed to correct for the higher HR and altered QRS-T wave morphology in rodents. High amplitude ECoG spiking was defined as sharp electrographic events three-times baseline voltage and counted using LabChart Spike Analysis over a 15 min bin. Movement artefacts were identified on the ECG and eliminated from the ECoG analysis.
Morphological characterisation of myocardial injury
48 h following KA or saline administration the animal was anaesthetised with halothane and the heart was excised. Hearts were arrested in diastole by flushing with 20 ml of ice-cold (4 8C) 0.9% saline containing 20 mM of KCl. The tissue was perfusionfixed (73.6 mmHg pressure) in situ and maintained in 10% neutral buffered formalin (4 h). Apical ventricular tissues (6 mm depth from apex) were paraffin-embedded and tissue sections (5 mm) prepared for staining with Martius scarlet blue (MSB). Qualitative histological evaluations were performed in a double-blind manner on 10 individual digital images from each section using an Axioplan-2 microscope and recorded with the Axiovision v.3.1 image analysis system (Carl Zeiss Ltd., Germany). Morphological features were then scored in a double-blind manner on 5 sequential fields from each ventricular section. Semi-quantitative analysis of fibrotic damage was conducted using Adobe Photoshop CS5 software in which the ratio of collagen stained (blue) pixels was calculated against background in each cardiac section.
Statistics
Statistical analysis was performed using Prism TM v.5 (GraphPad, San Diego, USA). Behavioural data were analysed using a Kruskal-Wallis test with Bonferroni post hoc. ECG variables were analysed using a 2-way repeated measures AVOVA with Bonferroni post hoc analysis. Statistical significance was determined as P < 0.05. Data are presented as mean AE standard error of the mean (SEM).
Results
Behavioural analysis
No differences in behaviour (exploring, grooming and sleeping) were exhibited by the three different treatment groups during the initial 20 min baseline period. Administration of KA resulted in an immediate period of hypoactivity (Table 1) with WDS occurring at 42.0 AE 1.8 min and Level 4 behaviours developing at 87.5 AE 11.9 min. Clonidine pre-treatment significantly increased the latency to onset of Level 4 behaviours (P < 0.05), however the duration of Level 4 activity was comparable (63.7 AE 7.0 and 73.0 AE 12.1 min post-KA in the saline-KA and clonidine-KA groups, respectively, NS).
The cumulative score for the saline-KA group over the 120 min observation period was 666 AE 53 (Fig. 1A) . The clonidine-KA group had a significantly lower cumulative score and number of WDS (P < 0.05 versus saline-KA) while no difference in the number of Level 4 behaviours was observed. KA administration resulted in an increase in the frequency of high amplitude spikes, with maximum spiking occurring during 105-120 min post-KA (1052 AE 255, respectively, Fig. 1B ) which was significantly reduced by clonidine pre-treatment (P < 0.05).
ECG analysis
KA administration immediately provoked a profound bradycardic response with a minimum HR of 258 AE 12 b.p.m. recorded 20 min post-KA (40.3% decrease from baseline, P < 0.001 versus saline-control; Figs. 2A and 3B ). HR subsequently increased ( Fig. 3D and E), reaching 15.9 AE 4.8% above baseline at 60 min and remained elevated until 95 min. Clonidine pretreatment significantly decreased baseline HR by 35% compared to the saline-control animals (281 AE 6 b.p.m. versus 432 AE 9 b.p.m. respectively), while clonidine pre-treatment did not attenuate KA-induced bradycardia ( Fig. 2A) it significantly reduced the subsequent tachycardic episode (P < 0.05 versus the saline-KA group).
QTc interval was significantly decreased 5 min post-KA (P < 0.05 versus baseline; Fig. 2B ) and as seizure activity in these animals increased, QTc interval became prolonged reaching significance at 60, 65 and 120 min post-KA administration. Pretreatment with clonidine had no effect on baseline QTc intervals but prevented the QTc prolongation.
KA administration in saline-KA animals resulted in a gradual increase in T wave amplitude, with a 22.8 AE 5.9% increase observed at 55 min (P < 0.005 versus baseline) and progressing to a maximum increase of 40.5 AE 12.0% observed 115 min post-KA (Fig. 2C) . Clonidine pretreatment did not affect T wave amplitudes during baseline, however it abolished the KA-induced amplification.
Individual time matched recordings of ECoG, HR and behavioural responses in saline-KA treated rats (Fig. 3F) showed that the bradycardic phase following KA administration was associated with little cortical spiking and low seizure behaviours. Skipped beats (Fig. 3C) were also noted on the ECG waveforms during this period. The subsequent increase in high amplitude ECoG spiking and seizure activity coincided with the development of tachycardia. Erratic HR activity occurred in several of the saline-KA treated animals, with abnormal depolarisation observed (Fig. 3D) . Pretreatment with clonidine prevented the KA-induction of tachycardia in conjunction with the decrease in seizure behaviours described (Fig. 3F) .
Cardiac morphology
Apical-midplane sections of left ventricular myocardium showed evidence of subendocardial damage at 48 h post-KA in Values represent the mean AE SEM of n = 10 in the saline-KA group and n = 5 in the clonidine-KA group. * P < 0.05 compared to saline-KA. saline-KA animals. Evidence of oedema and myocyte vacuolisation, indicative of early reversible ischaemic damage, 23 was found throughout the subendocardium (Fig. 4B and C) . Hypercontraction band necrosis, muscle fibre degeneration, inflammatory cell infiltration and collagen deposits were observed in the saline-KA sections (Fig. 4D) . In contrast, tissue sections taken from clonidine-KA animals ( Fig. 4E ) bore minimal evidence of cardiac damage, the appearance of the myocardial basement membrane remained intact with minimal oedema or ischaemic injury seen 48 h post-KA. KA administration in saline-KA animals resulted in an increase in collagen deposition, indicative of fibrosis (0.7 AE 0.2% versus 0.1 AE 0.03% in the control-saline group, P < 0.05) which was completely prevented by pretreatment with clonidine (P < 0.05 compared to saline-KA, Fig. 4F ). The extent of collagen deposition, and inflammatory cell infiltration throughout the ventricular sections of the untreated saline-KA rats is shown in Fig. 5 and key morphological scores of the saline-versus clonidine-pretreated KA groups examined are tabulated in Table 2 .
Discussion
This study showed that clonidine administration prior to KAinduced seizures significantly reduced ECG changes and improved cardiac morphology. KA administration resulted in a rapid induction of hypoactivity followed by WDS behaviours before developing limbic seizures. 21 Clonidine was effective in slowing the onset to seizure behaviours, decreasing cumulative seizure score and WDS behaviours. This was similar to previous reports where clonidine decreased WDS and protected against limbic seizures.
24,25
Previous studies have shown that systemic KA can decrease HR by 22% within 30 min in rats. 26 In urethane anaesthetised rats, KA administration enhanced autonomic activity with animals experiencing impaired baroreceptor reflex and bradyarrhythmias. 27 Rats died due to profound cardiac dilation leading to hypoperfusion of the heart and brain. Other groups have shown that KA-induced seizures in the same anaesthetised model can produce a 15% increase in HR which correlated with a 2-fold increase in cardiac sympathetic nerve activity. 28 Each of these animal studies has provided valuable insights into the mechanisms of sudden death following SE but also conflict as to the significance of tachyarrhythmias in sudden cardiac death. The present study avoided the confounding effects of anaesthetics on resting cardiovascular function and seizurogenic responses. 20 By using in vivo telemetry to simultaneously record ECoG and ECG in conscious animals, our study clearly showed that KA administration produces a profound bradycardic response associated with low seizure behaviours and spiking which may reflect a centrally evoked vagal outflow. The subsequent tachycardia is likely associated with increased stimulation of cardiac sympathetic outflow during high seizure activity. Clonidine administration resulted in a significant decrease in baseline HR similar to clinical and animal studies 19, 29 and blunted the severity of KA-induced bradycardia. Studies examining QT prolongation have shown that clonidine administration results in an increased RR interval without altering the baseline QTc interval. 29, 30 In the current study, clonidine pretreatment decreased baseline HR and attenuated QTc prolongation and T wave amplification consequent to seizure induction. The QT interval is an established risk factor for lifethreatening 'Torsade de Pointes' tachycardia and sudden cardiac death as it forms a measure of ventricular repolarisation and hence ventricular perfusion. 31 A transient increase in the QT interval, as observed during epileptic discharge, can be provoked by a sympathetic stimulatory surge or abnormal ion channel function which can predispose to ventricular fibrillation and sudden death. [31] [32] [33] Conversely, QT shortening caused by circulating catecholamines and enhanced by hyperkalaemia or acidosis, can facilitate re-entrant excitation leading to fatal arrhythmias. 33 As this study used continuous monitoring, we were unable to investigate the possibility of electrolyte disturbances without compromising our experimental protocol.
The cardiac morphological features observed in the rats following the onset of SE showed clear evidence of early structural damage which closely resembled findings at post-mortem in patients with epilepsy. Structural changes have been reported in 33% of epileptic patients 4 with evidence of fibrosis, reversible myocyte vacuolisation, leukocytic infiltration and oedema found post-mortem. [34] [35] [36] In our seizure model, interstitial oedema was clearly observed in all ventricular planes and nuclear vacuolisation, an early marker of reversible ischaemic damage, was visible in the saline-KA hearts which is consistent with previous findings. 14, 23 Surprisingly, interstitial fibrosis, resembling that observed soon after isoproterenol administration in a rat model, 23 could be found encapsulating the necrotic regions as early as 48 hours after the original insult. The use of traditional anti-epileptic drugs to terminate seizure activity was avoided in this study due to the detrimental effects of these agents on cardiac function. Aggressive use of anti-epileptic agents have been indicated to have adverse cardio-respiratory effects. 16 Benzodiazepines and barbiturates can provoke respiratory depression and hypotension 37 with the development of adverse reflex tachycardia. Na + channel antagonists such as phenytoin and carbamazapine can also promote hypotension and cardiac arrhythmias in a significant proportion of patients, necessitating the use of cardio-respiratory monitoring. 38 Consequently, the adjunct use of pharmacological agents with mixed sympatholytic and parasympathomimetic actions such as clonidine, 18 to reduce cardiac repercussions of sympathetic overdrive and seizure activity in SE may be therapeutically advantageous. By reducing tachycardia and diminishing the QT changes invoked by seizure induction, this study suggests that clonidine is effective in protecting ventricular structure during seizure. The behavioural and epileptiform responses suggest that clonidine has the ability to delay the onset of seizure and retard epileptiform activity. 39 While reduction of cardiac damage following pretreatment with clonidine may relate to the attenuation of seizure activity, recent studies have demonstrated that cardiac b 1 receptor blockade can also reduce cardiac dysfunction in SE. 40 The data presented here strongly suggests that the reduction of sympathetic surge during SE will contribute to the prevention of cardiac damage and may ultimately reduce patient mortality.
Conclusions
The results obtained in this study bear a strong resemblance to clinical data and clearly show that ECG abnormalities and structural heart damage occur rapidly after the onset of SE. While predictors of pre-ictal states are valuable in optimising prophylactic anti-epileptic measures, 41 our study highlights the importance of protecting the myocardium during SE.
